Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit
cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at
opm.gov.
Analysis shows return on investment for global health R&D
January / February 2017 | Volume 16, Issue 1
Research and development for new health technologies are essential to solving the world's greatest global health challenges, according to the Global Health Technologies Coalition (GHTC). A set of infographics available to download on the organization's website illustrates the impact of global health R&D investments, the funding and pipeline of products for neglected diseases, and the ongoing need for development of new technologies.
Support for R&D has a multiplier effect, the GHTC notes, not only saving and improving lives, but also reducing costs, encouraging economic growth and enhancing global security. “Investment in global health R&D drives job creation, spurs business activity and benefits academic institutions: nearly 64 cents of every U.S. dollar spent on global health R&D goes directly to U.S.-based researchers,” the website reports.
U.S.-funded global health research has supported such breakthroughs as antiretroviral drugs for HIV/AIDS, improved diagnostics for infectious diseases, new contraceptive technologies and a new vaccine to combat malaria.
More Information
Text of the chart "Critical US role in global health R&D":
- 55 percent of products in the global pipeline are supported by the US government
- 45 percent of total investment in global health R&D (public, private, philanthropic) is contributed by the US government
- 70 percent of public sector investment in global health R&D is contributed by the US government
- Less than .01 percent of US GDP is spent annually on global health R&D
To view Adobe PDF files,
download current, free accessible plug-ins from Adobe's website.